Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 13/20 | 0.58 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.58 |
| ▸ | SMPD1 | P17405 | 5/20 | 0.52 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.52 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4638947 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL60846 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL7188409 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2695072 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL1044717 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL62052 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL418810 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL2693656 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL632447 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 | |
| SCHEMBL905578 | 1.00 | FDPS (0.58) | FDPSGGPS1SMPD1LPAR1LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2100 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048072-A1 | PHARMACEUTICAL PREPARATION FOR INTRANASAL ADMINISTRATION AND PREPARATION METHOD THEREFOR | CHENGDU EASTON BIOPHARMACEUTICALS CO LTD (CN) | 2026-02-19 | — | — | US | claimed |
| US-12508229-B2 | Method for preparing stable peptide formulations | AMPHASTAR PHARMACEUTICALS, INC. (US) | 2025-12-30 | — | — | US | claimed |
| EP-4658240-A2 | PHARMACEUTICAL COMPOSITIONS FOR NASAL DELIVERY | Therakind Limited (GB) | 2025-12-10 | — | — | EP | claimed |
| EP-3958838-B1 | METHOD FOR PREPARING STABLE PEPTIDE FORMULATIONS | AMPHASTAR PHARMACEUTICALS INC (US) | 2025-09-10 | — | — | EP | claimed |
| US-12370241-B2 | Nasal powder formulation for treatment of hypoglycemia | AMPHASTAR PHARMACEUTICALS, INC. (US) | 2025-07-29 | — | — | US | claimed |
| US-20250205311-A1 | PHARMACEUTICAL COMPOSITIONS OF SEMAGLUTIDE AND THE METHODS OF USE THEREOF | PENTIDE THERAPEUTICS LTD (CN) | 2025-06-26 | — | — | US | claimed |
| EP-3673900-B1 | NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA | AMPHASTAR PHARMACEUTICALS INC (US) | 2025-06-25 | — | — | EP | claimed |
| EP-3673899-B1 | NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA | AMPHASTAR PHARMACEUTICALS INC (US) | 2025-06-25 | — | — | EP | claimed |
| EP-4514376-A1 | PHARMACEUTICAL COMPOSITIONS OF SEMAGLUTIDE AND THE METHODS OF USE THEREOF | Pentide Therapeutics Limited (HK) | 2025-03-05 | — | — | EP | claimed |
| US-12226456-B2 | Nasal powder formulation for treatment of hypoglycemia | AMPHASTAR PHARMACEUTICALS, INC. (US) | 2025-02-18 | — | — | US | claimed |
| WO-2005007895-A1 | METHODS AND KITS FOR OBTAINING NUCLEIC ACID FROM BIOLOGICAL SAMPLES | APPLERA CORPORATION (US) | 2005-01-27 | — | — | WO | claimed |
| US-20050009036-A1 | Methods and kits for obtaining nucleic acid from biological samples | APPLERA CORPORATION (US) | 2005-01-13 | — | — | US | claimed |
| US-20040072796-A1 | Method and composition for preventing pain in sickle cell patients | TRF PHARMA, INC. | 2004-04-15 | — | — | US | claimed |
| WO-2003088980-A1 | METHOD AND COMPOSITION FOR PREVENTING PAIN IN SICKLE CELL PATIENTS | EMBURY STEPHEN H (US) | 2003-10-30 | — | — | WO | claimed |
| US-20030199672-A1 | Derivatives of GLP-1 analogs | KNUDSEN LISELOTTE BJERRE (DK) | 2003-10-23 | — | — | US | claimed |
| US-20030018169-A1 | Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides | AMYLIN PHARMACEUTICALS, INC. | 2003-01-23 | — | — | US | claimed |
| US-6451543-B1 | PREFOLDED MEMBRANE POLYPEPTIDE EMBEDDED WITHIN A LIPID MATRIX VIA STEPWISE CHEMOSELECTIVE CHEMICAL LIGATION OF UNPROTECTED PEPTIDE SEGMENTS, WHERE AT LEAST ONE PEPTIDE SEGMENT IS EMBEDDED IN A LIPID MATRIX. | GRYPHON SCIENCES | 2002-09-17 | — | — | US | claimed |
| US-20010011071-A1 | DERIVATIVES OF GLP-1 ANALOGS | KNUDSEN LISELOTTE BJERRE (DK) | 2001-08-02 | — | — | US | claimed |
| EP-1107979-A2 | LIPID MATRIX-ASSISTED CHEMICAL LIGATION AND SYNTHESIS OF MEMBRANE POLYPEPTIDES | Gryphon Sciences (US) | 2001-06-20 | — | — | EP | claimed |
| WO-2000012536-A2 | LIPID MATRIX-ASSISTED CHEMICAL LIGATION AND SYNTHESIS OF MEMBRANE POLYPEPTIDES | GRYPHON SCIENCES (US) | 2000-03-09 | — | — | WO | claimed |